Series B Therapeutics Companies

Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.

Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases.

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

FeetMe is a digital health company that provides a technology platform for in-clinic and real-world gait and activity assessments.

Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.

Lion TCR is a clinical-stage biotechnology company.

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

Advanced NanoTherapies researcehes biodegradable functionalized nanoparticle technology.

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Edge Animal Health offers biotechnology solutions that focus on a bi-directional approach to develop novel therapeutics and vaccines.

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

Invirsa develops a molecule that promotes ocular DNA repair and the innate immune response to infection and injury.

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.